JDD Corner

Most Patient-Oriented Video Resources Do Not Comprehensively Explain Mohs Micrographic Surgery
Mohs Micrographic Surgery (MMS)INTRODUCTION Mohs micrographic surgery (MMS) is increasingly utilized for treatment of skin cancer, however the technique used is markedly different than other surgical modalities.1,2 Explaining MMS to patients is difficult, and anxiety following a skin cancer diagnosis likely leads many to seek out additional resources to supplement their understanding.3,4 It is unclear how accurate and comp …
Mohs Micrographic Surgery (MMS)
Laboratory Testing in Telogen Effluvium
Telogen Effluvium (TE) Telogen effluvium (TE) – a common cause of non- scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices. INTRODUCTION Telogen effluvium (TE) – a common cause of non-scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices. While endocrine, vitamin, and mineral abnormalities …
Telogen Effluvium (TE)
Acne Information on Instagram: Quality of Content & the Role of Dermatologists on Social Media
acneINTRODUCTION Common among adolescents and adults, acne vulgaris accounts for a significant portion of dermatology appointments.1 While there are a variety of safe, effective, and evidence-based treatments available, there are also numerous products for acne marketed on social media that are untested and/or show no benefit in treating acne vulgaris. Even for treatments with known efficacy, quality …
acne
JDD Issue Highlights | March 2022
The March 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from acne and psoriasis to Platelet Rich Plasma (PRP) for scarring alopecia and racial differences and their impact on treatment for hidradenitis suppurativa, we share this month’s issue highlights straight from the JDD Editor’s de …
Chromate-Induced Allergic Contact Dermatitis Treated With Dupilumab
Chromate-Induced Allergic Contact Dermatitis Treated With DupilumabChromate causes persistent, difficult to treat irritant and allergic contact dermatitis in cement-handling occupational workers. When therapeutics such as topical corticosteroids, topical calcineurin inhibitors, phototherapy and immune-modulating treatments like methotrexate fail, many patients are advised that avoidance may be the only remaining option – an option that may be particularly chall …
Chromate-Induced Allergic Contact Dermatitis Treated With Dupilumab